Rowland Thomas Andrew 4
4 · ANI PHARMACEUTICALS INC · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Transactions
- Tax Payment
Common Stock
2024-11-15$56.58/sh−867$49,055→ 33,169 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,000 shares of restricted stock, the grant of which was previously reported.